1969P The SGLT2 inhibitor dapagliflozin enhanced anticancer activities and exerts cardioprotective effects against doxorubicin and trastuzumab toxicity through TLR4, MyD88, NF-kB signaling and NLRP3 inflammasome pathwayNicola Maurea, Gerardo Botti, I Grimaldi et al.|Annals of Oncology|2020Cited by 7
1944P Hyperglycemia increased nivolumab-induced cardiotoxicity, enhanced immunoresistance of ERɑ+, PR+, HER2- breast cancer cells modulating growth factors and NLRP3 expressionVincenzo Quagliariello, Nicola Maurea, Annamaria Bonelli et al.|Annals of Oncology|2020Cited by 2